All I know is commercial revenue, excluding BARDA, is supposed to be US$10-11m. We'll find out the exact number in the morning (along with other updates) but I'd have varying degrees of happiness within this range. $10m would still be a respectable 6% growth on Q422 or 34% growth on Q122 which shows continued penetration into the U.S. and Japan burns markets.
Since this is Jim's first quarterly revenue guidance, my gut feeling is he would've pushed to get to at least US$10.3m. If they achieve this, it'll provide more confidence that he's a man who delivers on his word.
I don't think we should expect to see exceptional sales results until at least Q323 when soft tissue repair has been (hopefully) launched.
- Forums
- ASX - By Stock
- AVH
- Ann: AVITA Medical to Announce First Quarter 2023 Results
Ann: AVITA Medical to Announce First Quarter 2023 Results, page-26
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
|
|||||
Last
$2.65 |
Change
-0.010(0.38%) |
Mkt cap ! $183.5M |
Open | High | Low | Value | Volume |
$2.68 | $2.68 | $2.64 | $145.1K | 54.70K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2579 | $2.64 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.70 | 315 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2579 | 2.640 |
1 | 9999 | 2.630 |
2 | 10300 | 2.620 |
3 | 8500 | 2.610 |
4 | 11400 | 2.600 |
Price($) | Vol. | No. |
---|---|---|
2.700 | 315 | 2 |
2.710 | 325 | 1 |
2.720 | 5 | 1 |
2.770 | 3367 | 3 |
2.780 | 6884 | 2 |
Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |